+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Gene Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Gene Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5950406
Free Webex Call
10% Free customization
Description Jump to:

Gene Editing Services is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Gene Editing Technologies Market, valued at USD 5.78 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 10.41 Billion by 2030. Gene editing technologies encompass methods enabling highly specific changes to an organism's DNA, facilitating the precise addition, removal, or alteration of genetic material at targeted genomic locations. The market's growth is primarily driven by continuous technological advancements, the expanding utility of gene editing across diverse applications, and increasing demand for personalized medicine. Furthermore, the rising global prevalence of genetic and chronic disorders, coupled with substantial government funding for related research, significantly contributes to market expansion.

Key Market Drivers

The global gene editing technologies market is profoundly influenced by continuous advancements in the precision and scope of gene editing tools. Innovations consistently emerge, enhancing the safety and accuracy of genetic modifications. For example, according to Massachusetts Institute of Technology, October 10, 2025, "MIT's new precision gene editing tool could transform medicine," a new system makes 60 times fewer mistakes than previous iterations, significantly improving targeting capabilities. These technological refinements directly enable the expanding therapeutic and research applications of gene editing. As tools become more reliable, the range of treatable diseases broadens, and the feasibility of complex genetic interventions increases. This expansion is evident in the burgeoning clinical pipeline.

Key Market Challenges

Persistent concerns regarding off-target effects present a significant impediment to the growth of the Global Gene Editing Technologies Market. These effects, where unintended genetic alterations occur at locations other than the targeted site, introduce substantial safety risks for patients. Such unpredictable outcomes necessitate extensive preclinical and clinical scrutiny, prolonging development timelines and increasing research expenditures. The inherent unpredictability associated with off-target editing directly influences regulatory bodies' cautious approach to product approvals, leading to more stringent testing requirements and extended observational periods for gene-edited therapies.

The impact of these safety concerns is reflected in development setbacks.

Key Market Trends

Accelerated Development of In Vivo Gene Therapies is a significant trend, representing a critical shift towards direct administration of genetic material into the body, thereby bypassing complex *ex vivo* cell manipulation. This approach offers broader therapeutic applicability, simpler administration, and reduced manufacturing complexities, particularly for systemic diseases or difficult-to-access tissues. According to Towards Healthcare, the *in vivo* gene therapy segment constituted approximately 55% of the gene therapy clinical trials market in 2024, indicating its substantial and growing prevalence. This modality is accelerating clinical development pathways.

Key Market Players Profiled:

  • Addgene Inc.
  • BRAIN Biotech AG
  • Cellectis S.A.
  • Creative Biolabs, Inc.
  • CRISPR Therapeutics AG
  • BioRad Laboratories, Inc.
  • DNA Script SAS
  • GeneCopoeia, Inc.
  • Merck KGaA
  • PerkinElmer Inc.

Report Scope:

In this report, the Global Gene Editing Technologies Market has been segmented into the following categories:

By Offerings:

  • Gene Editing Products
  • Gene Editing Services

By Technology:

  • CRISPR Gene Editing Technology
  • Non-CRISPR Gene Editing Technology

By Application:

  • Agricultural
  • Biomedical

By End User:

  • Academic Institutes and Research Centers
  • Life Sciences Companies
  • Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs)

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Editing Technologies Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Gene Editing Technologies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Offerings (Gene Editing Products, Gene Editing Services)
5.2.2. By Technology (CRISPR Gene Editing Technology, Non-CRISPR Gene Editing Technology)
5.2.3. By Application (Agricultural, Biomedical)
5.2.4. By End User (Academic Institutes and Research Centers, Life Sciences Companies, Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs))
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Gene Editing Technologies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Offerings
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Gene Editing Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Offerings
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Gene Editing Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Offerings
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Gene Editing Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Offerings
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Gene Editing Technologies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Offerings
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gene Editing Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Offerings
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. France Gene Editing Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Offerings
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Gene Editing Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Offerings
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Gene Editing Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Offerings
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Gene Editing Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Offerings
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Gene Editing Technologies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Offerings
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Gene Editing Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Offerings
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Gene Editing Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Offerings
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Gene Editing Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Offerings
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Gene Editing Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Offerings
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Gene Editing Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Offerings
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Middle East & Africa Gene Editing Technologies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Offerings
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gene Editing Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Offerings
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. UAE Gene Editing Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Offerings
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. South Africa Gene Editing Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Offerings
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Gene Editing Technologies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Offerings
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gene Editing Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Offerings
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Colombia Gene Editing Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Offerings
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Argentina Gene Editing Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Offerings
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Gene Editing Technologies Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Addgene Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. BRAIN Biotech AG
15.3. Cellectis S.A.
15.4. Creative Biolabs, Inc.
15.5. CRISPR Therapeutics AG
15.6. BioRad Laboratories, Inc.
15.7. DNA Script SAS
15.8. GeneCopoeia, Inc.
15.9. Merck KGaA
15.10. PerkinElmer Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Gene Editing Technologies market report include:
  • Addgene Inc.
  • BRAIN Biotech AG
  • Cellectis S.A.
  • Creative Biolabs, Inc.
  • CRISPR Therapeutics AG
  • BioRad Laboratories, Inc.
  • DNA Script SAS
  • GeneCopoeia, Inc.
  • Merck KGaA
  • PerkinElmer Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.41 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

CRISPR Gene Editing Market Report 2025 - Product Image

CRISPR Gene Editing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gene Editing Market Report 2025 - Product Image

Gene Editing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), by Application (Biomedical, Agricultural), by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), by Application (Biomedical, Agricultural), by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Microbial Gene Editing Service Market - Global Forecast 2025-2030 - Product Image

Microbial Gene Editing Service Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Gene Editing Market Size, Share, Growth, and Forecasts 2025-2033 - Product Image

Gene Editing Market Size, Share, Growth, and Forecasts 2025-2033

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.